SEC Form 4 · accession 0001735276-18-000064
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yvonne Greenstreet
Officer — EVP, Chief Operating Officer
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | S | 2,500 | $120.00 | D | 1,916 | D | |
| Common StockF2 | holding | — | — | — | 308 | I | by Managed Account |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 17, 2018.
- F2Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.